Pentraxin 3 in patients with type 2 diabetes and nonalcoholic fatty liver disease: a promising treatment target for glucagon-like peptide-1 receptor agonists. Authors' reply.

Authors :: Waluś-Miarka M
Kapusta M
Miarka P
Trojak A
Idzior-Waluś B
Małecki MT
Source :: Polish archives of internal medicine [Pol Arch Intern Med] 2019 Sep 30; Vol. 129 (9), pp. 649-650. Date of Electronic Publication: 2019 Sep 30.
Publication Year :: 2019

Subjects :: C-Reactive Protein
Glucagon-Like Peptide-1 Receptor
Humans
Serum Amyloid P-Component
Diabetes Mellitus, Type 2
Non-alcoholic Fatty Liver Disease

Full Text Access

Tools